KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Goodwill (2016 - 2025)

Historic Goodwill for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $18.7 billion.

  • Amgen's Goodwill rose 23.07% to $18.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.7 billion, marking a year-over-year increase of 23.07%. This contributed to the annual value of $18.7 billion for FY2025, which is 23.07% up from last year.
  • Amgen's Goodwill amounted to $18.7 billion in Q4 2025, which was up 23.07% from $18.7 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Goodwill ranged from a high of $18.7 billion in Q4 2025 and a low of $14.7 billion during Q3 2021
  • In the last 5 years, Amgen's Goodwill had a median value of $15.5 billion in 2023 and averaged $16.7 billion.
  • Its Goodwill has fluctuated over the past 5 years, first decreased by 6.81% in 2021, then skyrocketed by 2030.43% in 2024.
  • Over the past 5 years, Amgen's Goodwill (Quarter) stood at $14.9 billion in 2021, then rose by 4.29% to $15.5 billion in 2022, then increased by 19.96% to $18.6 billion in 2023, then increased by 0.04% to $18.6 billion in 2024, then rose by 0.23% to $18.7 billion in 2025.
  • Its Goodwill stands at $18.7 billion for Q4 2025, versus $18.7 billion for Q3 2025 and $18.7 billion for Q2 2025.